Cationic compounds and their use as macro molecular carriers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 25, 2006
Grant Date -
N/A
app pub date -
Sep 23, 1999
filing date -
Sep 23, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Dendrimers comprising a dentritic polypeptide with one dendron having terminal cationic groups and a lipidic anchor, preferably comprising C.sub.6-24-alkyl group containing .alpha.-amino acyl groups, preferably joined to the focal group, are used to assist transfection of cells in vitro and in vivo by DNA. The complex of dendrimer and DNA may be used in gene therapy, for instance to delivery clotting factor genes to cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully